Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 735191, 8 pages
http://dx.doi.org/10.1155/2012/735191
Research Article

A Six-Month Supplementation of Mulberry, Korean Red Ginseng, and Banaba Decreases Biomarkers of Systemic Low-Grade Inflammation in Subjects with Impaired Glucose Tolerance and Type 2 Diabetes

1Department of Food and Nutrition, Sookmyung Women’s University, Yongsan-gu, Seoul 140-742, Republic of Korea
2Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital The Catholic University of Korea, Seocho-gu, Seoul 137-701, Republic of Korea
3Department of Preventive Medicine, Seoul St. Mary’s Hospital The Catholic University of Korea, Seocho-gu, Seoul 137-701, Republic of Korea
4Korea Ginseng Manufacturing Plant, National Agricultural Cooperative Federation, Chung-buk 368-811, Republic of Korea
5Clinical Nutrition & Risk Factor Modification Center, St. Michael's Hospital and, Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada M5C 1N8

Received 5 October 2011; Revised 19 December 2011; Accepted 20 December 2011

Academic Editor: Cheorl-Ho Kim

Copyright © 2012 H.-J. Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Jessani, T. Millane, and G. Y. Lip, “Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?” Current Pharmaceutical Design, vol. 15, no. 29, pp. 3417–3432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Amini, N. Horri, M. Zare et al., “People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients,” Annals of Nutrition and Metabolism, vol. 56, no. 4, pp. 267–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, and U. Smith, “Inflamed adipose tissue, insulin resistance and vascular injury,” Diabetes/Metabolism Research and Reviews, vol. 24, no. 8, pp. 595–603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Guilherme, J. V. Virbasius, V. Puri, and M. P. Czech, “Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 5, pp. 367–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. I. Shulman, “Cellular mechanisms of insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 2, pp. 171–176, 2000. View at Google Scholar · View at Scopus
  7. C. de Luca and J. M. Olefsky, “Inflammation and insulin resistance,” FEBS Letters, vol. 582, no. 1, pp. 97–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. F. Semenkovich, “Insulin resistance and atherosclerosis,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1813–1822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Monnier, E. Mas, C. Ginet et al., “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1681–1687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Vuksan, M. K. Sung, J. L. Sievenpiper et al., “Korean red ginseng (panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Y. Park, K. S. Lee, and M. K. Sung, “Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions,” Life Sciences, vol. 77, no. 26, pp. 3344–3354, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Chen, N. Nakashima, I. Kimura, M. Kimura, N. Asano, and S. Koya, “Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozotocin diabetic mice,” Biological & Pharmaceutical Bulletin, vol. 18, no. 12, pp. 1676–1680, 1985. View at Google Scholar
  13. G. Klein, J. Kim, K. Himmeldirk, Y. Cao, and X. Chen, “Antidiabetes and anti-obesity activity of Lagerstroemia speciosa,” Evidence-based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 401–407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 26, supplement 1, pp. S5–S20, 2003. View at Google Scholar · View at Scopus
  15. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar
  16. T. Temelkova-Kurktschiev, G. Siegert, S. Bergmann et al., “Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes,” Metabolism, vol. 51, no. 6, pp. 743–749, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Festa, R. D'Agostino, G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Google Scholar · View at Scopus
  18. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, pp. 115–126, 1999. View at Google Scholar · View at Scopus
  19. B. D. Schaan, V. L. Portal, M. T. O. de Ugarte, A. A. Dias, and D. M. Hatem, “Emerging risk factors and early atherosclerosis indices in subjects with impaired glucose tolerance,” Diabetes and Metabolism, vol. 31, no. 6, pp. 581–587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. B. Hu, M. J. Stampfer, S. M. Haffner, C. G. Solomon, W. C. Willett, and J. E. Manson, “Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes,” Diabetes Care, vol. 25, no. 7, pp. 1129–1134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. B. Meigs, F. B. Hu, N. Rifai, and J. E. Manson, “Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 291, no. 16, pp. 1978–1986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. O. T. Njajou, A. M. Kanaya, P. Holvoet et al., “Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the health, aging and body composition study,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 8, pp. 733–739, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Matsuzawa-Nagata, T. Takamura, H. Ando et al., “Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity,” Metabolism, vol. 57, no. 8, pp. 1071–1077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999. View at Google Scholar
  25. M. Nakhjavani, F. Asgharani, O. Khalilzadeh et al., “Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus,” The American Journal of the Medical Sciences, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. K. Reddy and T. Hashimoto, “Peroxisomal β-oxidation and peroxisome proliferator—activated receptor α: an adaptive metabolic system,” Annual Review of Nutrition, vol. 21, pp. 193–230, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Jung, S. Song, and C. Choi, “Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species,” Immunology Letters, vol. 117, no. 1, pp. 63–69, 2008. View at Google Scholar
  28. A. C. Montezano, F. Amiri, R. C. Tostes, R. M. Touyz, and E. L. Schiffrin, “Inhibitory effects of PPAR-γ on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats,” Journal of the American Society of Hypertension, vol. 1, no. 2, pp. 150–160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Defronzo, M. A. Banerji, G. A. Bray et al., “Determinants of glucose tolerance in impaired glucose tolerance at baseline in the actos now for prevention of diabetes (ACT NOW) study,” Diabetologia, vol. 53, no. 3, pp. 435–445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. S. Wolever and C. Mehling, “Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance,” American Journal of Clinical Nutrition, vol. 77, no. 3, pp. 612–621, 2003. View at Google Scholar · View at Scopus
  31. C. Tarirai, A. M. Viljoen, and J. H. Hamman, “Herb-drug pharmacokinetic interactions reviewed,” Expert Opinion on Drug Metabolism and Toxicology, vol. 6, no. 12, pp. 1515–1538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. S. Yuan, G. Wei, L. Dey et al., “Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial,” Annals of Internal Medicine, vol. 141, no. 1, pp. 23–27, 2004. View at Google Scholar · View at Scopus
  33. R. I. Shader and D. J. Greenblatt, “Bees, ginseng and MAOIs revisited,” Journal of Clinical Psychopharmacology, vol. 8, no. 4, p. 235, 1988. View at Google Scholar · View at Scopus
  34. S. H. Fang, Y.-C. Hou, and P.-D. Chao, “Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin,” Toxicology and Applied Pharmacology, vol. 205, no. 1, pp. 65–70, 2005. View at Publisher · View at Google Scholar
  35. M. Nagai, T. Fukamachi, M. Tsujimoto et al., “Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3),” Biological and Pharmaceutical Bulletin, vol. 32, no. 1, pp. 105–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Karami-Mohajeri and M. Abdollahi, “Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: a systematic review,” Human and Experimental Toxicology, vol. 30, no. 9, pp. 1119–1140, 2011. View at Publisher · View at Google Scholar